The transplants occurred in January at three Chicago hospitals.

Dr. Michael Millis, chief of the transplantation system at the University of Chicago Hospitals, said his staff was told of the issue on Nov. 1, and earned the two patients who had transplants there for screening the next morning. It was very astonishing and devastating for them, I’ll be honest, just as it will be for any of us, Millis said. Exams on the donor for HIV, hepatitis and various other conditions returned negative, most likely as the donor had obtained the infections in the last three weeks before loss of life. Personal stats about the donor weren’t released by medical official officials, who cited personal privacy laws. Predicated on the negative test results, doctors at Northwestern Memorial Medical center, Rush University INFIRMARY and the University of Chicago INFIRMARY went forward with the transplants, predicated on the negative test results.Haffty, MD, ASTRO 2014 President-elect 3:15 p.m. – 4:00 p.m. Advancements in Prostate Malignancy Moderated by Colleen A. Lawton, MD, Wednesday ASTRO 2013 President-elect, October 31:7:00 a.m. – 7:45 a.m. Targeted Radiation +/ – Biologics Moderated by Catherine Park, MD, vice-chair of 2012 Annual Meeting Education Committee, and Eric Lin Chang, MD, person in the 2012 Annual Meeting Scientific Committee.

Acino recognized with 2014 European countries Frost & Sullivan Award for Enabling Technology Leadership Based on its recent evaluation of the prescription delivery market, Frost & Sullivan recognizes Acino Pharma AG with the 2014 Europe Frost & Sullivan Award for Enabling Technology Leadership.